Skip to content

Association of Intraoperative Hemodynamic Characteristics to Postoperative Complications and Mortality

Association of Intraoperative Hemodynamic Characteristics to Postoperative Complications and Mortality

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06355362
Acronym
HeCoMo
Enrollment
1000
Registered
2024-04-09
Start date
2024-09-01
Completion date
2025-06-30
Last updated
2024-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-risk Surgery

Keywords

hemodynamic, transfusion, perioperative process quality, intensive care medicine, complications, mortality

Brief summary

Worldwide, about 400 million major surgeries are performed annually. The scarce data available in the literature still suggest high postoperative morbidity and mortality, even in Europe. Data of the World Health Organization on causes of death suggest that death after surgery would be the number three cause of mortality if it were considered a separate cause of death. However, there is little structured or high-quality data on postoperative mortality in the literature. The aim of this study project is to collect data on postoperative complications and mortalities worldwide and to establish a Perioperative Outcome Study Platform on this topic. In the first study of this platform, we aim to investigate the association of hemodynamic characteristics with postoperative complications and mortality. It is a prospective, multi-center study. In addition, the investigators aim to collect data on the structural characteristics of the study sites and, for each patient, characteristics of quality of perioperative care in order to analyze associations with hemodynamic characteristics and postoperative complications and mortalities.

Detailed description

Preamble The Perioperative Outcome (POP-OUT) project aims to improve care for our patients and intends to build a community of physicians from all over the world being dedicated to that aim. The purpose and vision of the Perioperative Outcome study project In perioperative care outcome data about postoperative mortality and morbidity is rare. This project aims to fill that gap with a prospective international database collecting perioperative data of surgical patients and relate them to postoperative mortality and morbidity. The project is planned as initial observational study to build up the structures and define the case. Subsequently, based on that initial project the investigators further develop the study platform. This platform should adapt, grow, and broaden according to the results and possibilities seen in the study generations year by year. The intention is not to set-up a study group that finishes its work if the study is performed, but they hand on the study to the next generation of the community. The vision is that in the future the outcome data offer the possibility to diversify, plan and power statistically prospective intervention trials to address the mortality and morbidity of our patients. The idea is to establish a global community of anesthetists and intensivists to develop such a study platform together. The community is stronger than everything else. The first steps of the study platform The goal is to start with an initial observational trial about hemodynamic perioperative characteristics (fluids, vasopressors, inotropes, transfusions, hypotensive events) and short- and long-term outcomes. The outcome measures should be in the short-term postoperative complications according to the classification of CLAVIEN-DINDO greater or equal to IIIb (example lists will be provided to the community, but the main point is that greater or equal to the category IIIB requires an intervention making it transparent in the documentation process). The long-term outcome will be mortality (in-hospital, three-months, or one-year mortality). The working title should be: Association of Hemodynamic characteristics to postoperative Complications and Mortality with the short title: HeCoMo. But it is like a pilot trial offering us the possibility to build up a platform structure to continuously develop perioperative outcome studies in all fields of perioperative care. Which patients to include in the first observational trial The initial main study population will be high-risk surgery, but this is not limited nor fixed for now nor for future projects. It will be up to the community which specialties we will include or if we stratify the surgical populations, but the actual plan is to define a positive list of surgeries to be included. As example we can list for abdominal procedures: * esophageal resection * gastric resection with intestinal anastomosis * pancreatic resections (whole organ, head, or tail) * multivisceral procedures, e.g., cancer debulking due to ovarian cancer * urological cystectomies. Study aims of the initial observational trial The primary hypothesis of the first observational trial is to test which hemodynamic measures are associated to postoperative morbidity or mortality. The measures to test are the cumulative amount and the longitudinal aspects of the intraoperative values of: * intravenous infusion volume * fluid balance * hypotensive events * vasopressor administration * administration of inotropes * any type of transfusions It must be stated that the innovation of the study is not the study design nor its fancy primary outcome measures or statistical analysis. The issue is that it is a question not explicitly addressed in the literature and international short- and long-term outcome are not available in this context. The idea is that every center includes 15-25 patients in the sequence of their appearance. But nevertheless, the study goal is of clinical relevance and will offer the opportunity to be published at a good scientific level. Data management An important feature is that the data should belong to the community. That means that after the initial primary publication of every study generation the data can be used for subsequent sub-analysis or to plan subsequent powered intervention studies. At the end the long-term goal of that project is that the data are owned by the community. The development of the electronic case report form is planned. The data acquisition will be in RedCap hosted on the server and the management of the Evangelische Kliniken Essen-Mitte, Essen, Germany by the Department of Anesthesiology, Intensive Care Medicine, and Pain therapy. The data can be entered in the system via a webpage or via smartphone or tablet online and offline. Ethical consent and vote by the competent authority Obtaining an ethical vote by the competent authority and depending on the vote perceiving informed consent is up to the local institutions. In some countries it may be possible to conceive a waiver of individual patient consent. But this must be cleared out at the national level by the national coordinators. An important argument for the waiver is that the study population is more representative and is not biased by selection bias. Additionally, the study participation is expected at no additional risk for the study patients. The general idea is that this project is a prospective, indefinite database related to perioperative outcome with sub-questions regarding hemodynamic, respiratory, metabolic, etc. issues. Funding of the project It is important to state that this project will have no funding by a medical society or any other entity. To be independently the study should be based by the voluntary activities of their contributors or by the departmental funding of any involved institution. However, during the development of the study platform it can be required to receive funding for maintaining data management structures or similar requirements. If the steering committee agrees on such a particular funding approach the community will be informed. The structure of the study group The idea is to define a steering committee and national coordinators. They are granted co-authorship for the resulting publication. But everybody taking responsibility and care of the project will be mentioned in the acknowledgements. An exact statement about authorship of any analysis of the project will be send to everybody involved in the study platform prior to the inclusion of the first study patient. The national coordinators take responsibility of the organization and recruitment of the study centers within his/her own country or region.

Interventions

None listed

Sponsors

Kliniken Essen-Mitte
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective surgery with increased postoperative morbidity and/or increased postoperative mortality

Exclusion criteria

* Patients undergoing surgery in the field of obstetrics * Age \< 18 years * Lack of written informed consent * Lack of language understanding * Unwillingness to store disease data on site and share anonymised data as part of the clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative complicationsFrom the time of surgery up to hospital discharge or up to the 30th postoperative dayThe postoperative complications are graded according to the CLAVIEN-DINDO classification
Incidence of postoperative mortalitiesFrom the time of surgery up to one year after surgery, during hospital stay, at three, six, or twelve months after surgeryThe incidence of postoperative mortality during the follow-up period

Secondary

MeasureTime frameDescription
Postoperative haemodynamic characteristicsTime period from the end of surgery up to the third postoperative dayThe longitudinal course and punctual values after surgery up to the third postoperative day of haemodynamic parameters like heart rate and mean arterial pressures and therapies such as infusion volumes and balances, and catecholamine administration
Co-morbidities of patientsAt the day of surgeryDescriptive data about the co-morbidities of the study patients
Transfusion of blood components and administration of coagulation factorsDuring hospital stay or up to the 30th postoperative dayThe number of transfusions of packed red blood cells, plasma, or thrombocytes as well as coagulation factors per patients
Score of the physical/pathological activity status of the patientsDuring the 48 hours prior to surgeryScore of the the exercise ability in metabolic equivalent of task units
Implementation rate of preoperative factors impacting postoperative outcomeDuring the 48 hours prior to surgeryImplementation rate in percentage of preoperative factors like fasting periods, preoperative carbohydrate drinks or the use of bowel preparations
Characteristics of perioperative care, time in perioperative units and the hospitalDuring hospital stay or up to the 30th postoperative dayLength of patient stay in the hospital, time pre- and postoperatively in hospital, stay in recovery room, post-anesthesia care unit, intensive care medicine.
Characteristics of provision of anesthesia and type of pain therapyTime period from the start of anaesthesia up to the third postoperative dayData about the type of anaesthesia and the drugs used with their doses as well as the drugs and methods and drugs to control pain
Implementation rate of items perioperatively impacting outcome within an Enhanced-Recovery-After-Surgery pathway descriptionDuring hospital stay or up to the 30th postoperative dayThe implementation rate in percentage of perioperative items related to perioperative treatment modalities
Clinical frailty scaleDuring the 48 hours prior to surgeryScore according to the clinical frailty scale in categories 1 to 9
Intraoperative hemodynamic characteristicsTime period during surgeryThe longitudinal course and punctual values during surgery of haemodynamic parameters like heart rate and mean arterial pressures and therapies such as infusion volumes and balances, and catecholamine administration

Contacts

Primary ContactAarne Feldheiser, MD, PhD
a.feldheiser@kem-med.com+4920117431001

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026